Our results showed that NAFLD is associated with many biochemical factors, including renal chemistry (SUA), liver chemistry (ALT), serum lipid (TG), and diabetic effects (C-Peptide and HOMA-IR), suggesting that a combination of these factors is more significant in predicting NAFLD among T2DM patients. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.